QIMA Life Sciences: your single partner from R&D to QC release, across Brazil, Europe & India. We cover formulation development, CDMO services, characterization, impurities & degradation profiling, dissolution testing, E&L, nitrosamines, method development, stability studies, clinical trials (Phase I-IV), BA/BE, pharmaceutical equivalence, GMP batch release and regulatory support for market authorization. One trusted CRO/CDMO network, three continents, every stage of your drug's journey — from molecule to market. Meet us at CPHI Milan 2026, stand 6H49 — let's talk about your next project.